Wells Fargo & Company Has Lowered Expectations for GoodRx (NASDAQ:GDRX) Stock Price
GoodRx (NASDAQ:GDRX – Free Report) had its target price reduced by Wells Fargo & Company from $8.00 to $7.00 in a report published on Tuesday,Benzinga reports. Wells Fargo & Company currently has an overweight rating on the stock. Several other research analysts have also commented on the company. KeyCorp cut their price target on GoodRx […]
GoodRx (NASDAQ:GDRX – Free Report) had its target price reduced by Wells Fargo & Company from $8.00 to $7.00 in a report published on Tuesday,Benzinga reports. Wells Fargo & Company currently has an overweight rating on the stock. Several other research analysts have also commented on the company. KeyCorp cut their price target on GoodRx […]
